This month, doctors in Boston will begin the BabySeq project, in which they will sequence the genomes of newborns to look for signs of diseases that begin in childhood. Robert Green, associate professor of medicine at Brigham and Women’s Hospital, is quoted.
Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, participated in an interview about the health risks of some dietary supplements, and whether the industry and the U.S. Food and Drug Administration are doing enough to protect consumers.
David J. Hunter, professor of medicine at Brigham and Women’s Hospital, authored this opinion peice about the recent PBS series “The Emperor of All Maladies.”
Some leading vitamin stores have announced that they were pulling from their shelves a group of supplements that may contain a dangerous stimulant. Pieter A. Cohen, assistant professor of medicine at Cambridge Health Alliance, is quoted.
Facing the loss of patent protection and profits on top-selling brands, drugmakers sometimes stop or sharply limit sales of drugs to force consumers to switch to a somewhat modified, newly patented version before generic rivals have a chance to get into the market. Jerry Avorn, professor of medicine at Brigham and Women’s Hospital, is quoted.
The Harvard-run New England Primate Medical Research Center has come under additional scrutiny following allegations that between 1999 and 2011, a dozen monkeys were found dead in their cages or euthanized at the center. Frederick Wang, professor of medicine at Brigham and Women’s Hospital, is quoted.
Sudden death, a mysterious and devastating outcome of epilepsy, could result from a brain stem shutdown following a seizure, researchers report. Although the idea is still preliminary, it’s engendering hope that neurologists are one step closer to intervening before death strikes. Michael Moskowitz, professor of neurology at Massachusetts General Hospital, is quoted.
